GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sinotherapeutics Inc (SHSE:688247) » Definitions » Current Accrued Expense

Sinotherapeutics (SHSE:688247) Current Accrued Expense : ¥0.0 Mil (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Sinotherapeutics Current Accrued Expense?

Sinotherapeutics's Current Accrued Expense for the quarter that ended in Mar. 2024 was ¥0.0 Mil.


Sinotherapeutics Current Accrued Expense Historical Data

The historical data trend for Sinotherapeutics's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinotherapeutics Current Accrued Expense Chart

Sinotherapeutics Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Current Accrued Expense
Get a 7-Day Free Trial - - - - -

Sinotherapeutics Quarterly Data
Dec18 Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Current Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Sinotherapeutics Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.


Sinotherapeutics Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Sinotherapeutics's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Sinotherapeutics (SHSE:688247) Business Description

Traded in Other Exchanges
N/A
Address
No. 515 Huanke Road, Room 205 and 207, Pilot Free Trade Zone, Shanghai, CHN, 201203
Sinotherapeutics Inc is engaged in the research and development, production and sales of generic drugs and CRO services.

Sinotherapeutics (SHSE:688247) Headlines

No Headlines